Monoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin Drugs - Wikidata - wikimedia - TriplyDB

Monoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin Drugs

Monoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin Drugs

http://www.wikidata.org/entity/Q26863621

about

RBC Adherence of Immune Complexes Containing Botulinum Toxin Improves Neutralization and Macrophage Uptake.Role of Homologous Fc Fragment in the Potency and Efficacy of Anti-Botulinum Antibody Preparations 'In-Format' screening of a novel bispecific antibody format reveals significant potency improvements relative to unformatted molecules.A sensitive three monoclonal antibodies based automatic latex particle-enhanced turbidimetric immunoassay for Golgi protein 73 detection.

P2860

Q33744802-009C2C3D-350F-46EB-9559-0964893903A1 Q33845127-0E01E946-8298-4DA9-9C2F-D5B0743DDA6E Q36175749-6D6F87C6-73B5-4C88-8724-BA5E4B14B429 Q37560881-721ED8B6-5D83-4662-B6ED-A7A1FE320F8B

P2860

Monoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin Drugs

http://www.wikidata.org/entity/Q26863621

description

2015 nî lūn-bûn

@nan

2015 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Monoclonal Antibody Combinatio ...... xt-Generation Anti-Toxin Drugs

@ast

Monoclonal Antibody Combinatio ...... xt-Generation Anti-Toxin Drugs

@en

Monoclonal Antibody Combinatio ...... xt-Generation Anti-Toxin Drugs

@nl

type

label

Monoclonal Antibody Combinatio ...... xt-Generation Anti-Toxin Drugs

@ast

Monoclonal Antibody Combinatio ...... xt-Generation Anti-Toxin Drugs

@en

Monoclonal Antibody Combinatio ...... xt-Generation Anti-Toxin Drugs

@nl

prefLabel

Monoclonal Antibody Combinatio ...... xt-Generation Anti-Toxin Drugs

@ast

Monoclonal Antibody Combinatio ...... xt-Generation Anti-Toxin Drugs

@en

Monoclonal Antibody Combinatio ...... xt-Generation Anti-Toxin Drugs

@nl

P1433

Q26863621-4A322FFC-5A75-401B-A14F-2744EB1F52B5

P1476

Q26863621-278BD821-1AE6-45BC-B070-F9EE05B557F8

P2093

Q26863621-3CE54D9B-535A-4843-AEF4-05C6249BDD46

Q26863621-5E00F632-B5C7-4883-AEF5-0AE0068DA74E

Q26863621-D4867CF2-ED1A-41F2-905D-98A62D4FAB0E

Q26863621-EEE22F64-DD02-4402-888C-222AB1E057D2

P275

Q26863621-40C94E9B-3264-4F4A-B543-0BBE15136324

P2860

Q26863621-01344C86-45F9-4E67-B9BB-63F7F832005A

Q26863621-01F84D00-FBFE-4F76-AFF2-4F64E528885E

Q26863621-0DDB3FED-AE5C-40B7-A965-A10D17845E31

Q26863621-0F94AFE5-9326-4F22-ADAE-E6F1257755CC

Q26863621-116AB1F8-10EA-4E25-BE9C-42F3C2021615

Q26863621-160AEEF9-2697-4280-A938-8ADDA66C637A

Q26863621-1A0A3D88-081E-4773-8267-A8B4A66D4A31

Q26863621-1A66101B-69A1-468B-874A-7F67AED2B807

Q26863621-20202B36-1407-4637-8DF5-397AF0D9F341

Q26863621-23781A3C-23BA-470A-B032-E49D2DF2C02D

P304

Q26863621-A9F3BB16-51A0-47BD-B58D-0C1558CCD0DD

P31

Q26863621-46179A26-2ED4-4E9F-B8DD-7BE09169ADD9

Q26863621-D9259A38-6378-4D65-AC7B-F395983A9015

P356

Q26863621-438F7580-B51E-49BB-B231-D4817B81F586

P407

Q26863621-E168F255-D081-486A-B676-1AF79A7F4E64

P433

Q26863621-9609446E-FA15-40D1-A16B-6FBF408E7332

P478

Q26863621-6EDD32E6-49E0-4F52-8DC5-097B34485B6F

P577

Q26863621-6395B26C-6B14-4930-8C18-AB93FE9C0910

P5875

Q26863621-2A1509CD-EB44-4BE7-8560-895C3042446E

P698

Q26863621-B9EDD5A1-80EC-4F38-99BD-EF12FFC5234B

P921

Q26863621-2FA9CE86-99AA-4DD4-9B6E-0C6FEA1023C8

Q26863621-6C587DD0-D272-4C87-AD1A-0EC55D138C19

Q26863621-7D3C6A5A-9823-46F5-A398-727FC8423B55

P932

Q26863621-13EFA1E9-69E9-4765-90B9-E68565B00D35

P356

P1433

P1476

Monoclonal Antibody Combinatio ...... xt-Generation Anti-Toxin Drugs

@en

P2093

Amram Torgeman

http://www.w3.org/2001/XMLSchema#string

Eran Diamant

http://www.w3.org/2001/XMLSchema#string

Eyal Ozeri

http://www.w3.org/2001/XMLSchema#string

Ran Zichel

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Botulinum Toxin as a Biological Weapon: Medical and Public Health Management

Bacterial toxins: a table of lethal amounts

Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax

Continuous cultures of fused cells secreting antibody of predefined specificity

Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease

Affinity enhancement of antibodies: how low-affinity antibodies produced early in immune responses are followed by high-affinity antibodies later and in memory B-cell responses

Monoclonal antibody-based therapies for microbial diseases

In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity

Characterization of botulinum neurotoxin type A neutralizing monoclonal antibodies and influence of their half-lives on therapeutic activity

Receptor-mediated endocytosis of immune complexes in rat liver sinusoidal endothelial cells is mediated by FcgammaRIIb2

P304

1854-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/TOXINS7061854

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277982038

http://www.w3.org/2001/XMLSchema#string

P698

26035486

http://www.w3.org/2001/XMLSchema#string

P921

monoclonal antibody

P932

4488679

http://www.w3.org/2001/XMLSchema#string